Primary FDA-Approved Indications
Consider cefprozil for acute otitis media, sinusitis, and streptococcal infections when beta-lactamase coverage is needed after first-line therapy.
Acute otitis media
FDA ApprovedChildren โฅ6 monthsModerate
Preferred in non-IgE penicillin allergy when amox-clav is not tolerated.
Acute bacterial rhinosinusitis
FDA ApprovedChildren and adolescentsModerate
Use when amoxicillin/clavulanate is contraindicated or second-line per guideline algorithms.
Streptococcal pharyngitis
FDA ApprovedChildren and adolescentsModerate
Reserve for non-anaphylactic penicillin allergy; confirm GAS by rapid test/culture.